| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| hypoxia-inducible factor 1 alpha subunit | 9 | 0 | 0 | 9 |
| RAR-related orphan receptor gamma | 24 | 0 | 0 | 24 |
| GLI family zinc finger 3 | 24 | 0 | 0 | 24 |
| AR protein | 39 | 0 | 0 | 39 |
| aldehyde dehydrogenase 1 family, member A1 | 12 | 0 | 0 | 12 |
| retinoic acid nuclear receptor alpha variant 1 | 25 | 0 | 0 | 25 |
| retinoid X nuclear receptor alpha | 26 | 0 | 0 | 26 |
| estrogen nuclear receptor alpha | 42 | 0 | 0 | 42 |
| peroxisome proliferator-activated receptor delta | 16 | 0 | 0 | 16 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 25 | 0 | 0 | 25 |
| activating transcription factor 6 | 10 | 0 | 0 | 10 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 11 | 0 | 0 | 11 |
| Histone H2A.x | 8 | 0 | 0 | 8 |
| thyroid hormone receptor beta isoform a | 13 | 0 | 0 | 13 |
| heat shock protein beta-1 | 9 | 0 | 0 | 9 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 22 | 0 | 0 | 22 |
| lamin isoform A-delta10 | 14 | 0 | 0 | 14 |
| Voltage-dependent calcium channel gamma-2 subunit | 13 | 0 | 0 | 13 |
| Glutamate receptor 2 | 13 | 0 | 0 | 13 |
| PPM1D protein | 9 | 0 | 0 | 9 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 20 | 0 | 0 | 20 |
| EWS/FLI fusion protein | 17 | 0 | 0 | 17 |
| G | 16 | 0 | 0 | 16 |
| cytochrome P450 2D6 | 11 | 0 | 0 | 11 |
| Interferon beta | 23 | 0 | 0 | 23 |
| HLA class I histocompatibility antigen, B alpha chain | 16 | 0 | 0 | 16 |
| Fibroblast growth factor receptor 1 | 0 | 2 | 7 | 9 |
| Fibroblast growth factor receptor 2 | 0 | 2 | 1 | 3 |
| Fibroblast growth factor receptor 4 | 0 | 2 | 1 | 4 |
| Fibroblast growth factor receptor 3 | 0 | 2 | 1 | 3 |
| Fibroblast growth factor receptor 4 | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 16 | 0 | 0 | 16 |
| Smoothened homolog | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 16 | 0 | 0 | 16 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 11 | 0 | 0 | 11 |
| Chain A, Ferritin light chain | 7 | 0 | 0 | 7 |
| USP1 protein, partial | 10 | 0 | 0 | 10 |
| Microtubule-associated protein tau | 9 | 0 | 0 | 9 |
| regulator of G-protein signaling 4 | 6 | 0 | 0 | 6 |
| euchromatic histone-lysine N-methyltransferase 2 | 26 | 0 | 0 | 26 |
| DNA topoisomerase type IB small subunit | 0 | 0 | 1 | 1 |
| DNA topoisomerase I | 0 | 0 | 1 | 1 |
| vitamin D3 receptor isoform VDRA | 10 | 0 | 0 | 10 |
| cytochrome P450 3A4 isoform 1 | 10 | 0 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit pi | 10 | 2 | 2 | 14 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 10 | 2 | 2 | 14 |
| Gamma-aminobutyric acid receptor subunit delta | 10 | 2 | 2 | 14 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 10 | 2 | 2 | 14 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 10 | 2 | 2 | 14 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 10 | 2 | 2 | 14 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 10 | 2 | 2 | 14 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 10 | 2 | 2 | 14 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 10 | 2 | 2 | 14 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 10 | 2 | 2 | 14 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 10 | 2 | 2 | 14 |
| Aryl hydrocarbon receptor | 0 | 0 | 2 | 2 |
| Nuclear receptor ROR-gamma | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 10 | 2 | 2 | 14 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 10 | 2 | 2 | 14 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 10 | 2 | 2 | 14 |
| G-protein coupled receptor 84 | 0 | 0 | 1 | 1 |
| GABA theta subunit | 10 | 2 | 2 | 14 |
| Gamma-aminobutyric acid receptor subunit epsilon | 10 | 2 | 2 | 14 |
| G-protein coupled receptor 84 | 0 | 0 | 1 | 2 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 12 | 0 | 0 | 12 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| thioredoxin reductase | 17 | 0 | 0 | 17 |
| GALC protein | 5 | 0 | 0 | 5 |
| nuclear receptor subfamily 1, group I, member 3 | 16 | 0 | 0 | 16 |
| glucocorticoid receptor [Homo sapiens] | 30 | 0 | 0 | 30 |
| estrogen-related nuclear receptor alpha | 28 | 0 | 0 | 28 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| arylsulfatase A | 6 | 0 | 0 | 6 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Bloom syndrome protein isoform 1 | 10 | 0 | 0 | 10 |
| geminin | 21 | 0 | 0 | 21 |
| peripheral myelin protein 22 | 9 | 0 | 0 | 9 |
| survival motor neuron protein isoform d | 8 | 0 | 0 | 8 |
| muscleblind-like protein 1 isoform 1 | 5 | 0 | 0 | 5 |
| ATP-binding cassette sub-family C member 3 | 0 | 25 | 0 | 25 |
| Multidrug resistance-associated protein 4 | 0 | 26 | 0 | 28 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 4 | 1 | 10 |
| Prolyl endopeptidase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 3 |
| Bile salt export pump | 0 | 30 | 0 | 30 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Renin | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 1 | 0 | 5 | 1 | 13 |
| Carbonic anhydrase 2 | 0 | 5 | 3 | 14 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 3 | 0 | 4 | 1 | 8 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 10 | 0 | 11 |
| Steryl-sulfatase | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 3 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C8 | 0 | 5 | 0 | 5 |
| Cytochrome P450 2D6 | 0 | 4 | 0 | 4 |
| Cytochrome P450 2A6 | 0 | 1 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 8 | 0 | 8 |
| 5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
| Androgen receptor | 0 | 15 | 1 | 17 |
| Translocator protein | 0 | 2 | 0 | 2 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Arachidonate 5-lipoxygenase-activating protein | 0 | 2 | 0 | 2 |
| Cytochrome P450 2B6 | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 4 | 0 | 4 | 1 | 8 |
| Carbonic anhydrase 6 | 0 | 4 | 1 | 8 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 1 | 1 | 2 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 0 | 0 | 1 |
| Endochitinase | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C19 | 0 | 5 | 0 | 5 |
| Delta-type opioid receptor | 0 | 3 | 0 | 3 |
| Mu-type opioid receptor | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 4 | 2 | 10 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 4 | 1 | 8 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 1 | 0 | 2 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 9 | 0 | 4 | 1 | 10 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase, alpha family | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 3 |
| Carbonic anhydrase | 0 | 2 | 0 | 3 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Delta carbonic anhydrase | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Endochitinase A1 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 4 | 1 | 6 |
| Canalicular multispecific organic anion transporter 1 | 0 | 25 | 0 | 25 |
| Carbonic anhydrase 4 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 15 | 0 | 3 | 0 | 4 |
| Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 4 | 0 | 7 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 4 | 1 | 9 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 4 | 1 | 9 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 12 | 0 | 0 | 12 |
| Sex hormone-binding globulin | 0 | 1 | 4 | 5 |
| Corticosteroid-binding globulin | 0 | 5 | 0 | 5 |
| Mineralocorticoid receptor | 1 | 11 | 7 | 21 |
| Mineralocorticoid receptor | 0 | 4 | 0 | 4 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 2 | 0 | 4 |
| Guanine nucleotide-binding protein G | 4 | 0 | 0 | 4 |
| Chain A, 2-oxoglutarate Oxygenase | 7 | 0 | 0 | 7 |
| pregnane X nuclear receptor | 28 | 0 | 0 | 28 |
| cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 3 | 0 | 0 | 3 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M2 | 0 | 5 | 2 | 10 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
| Muscarinic acetylcholine receptor M1 | 0 | 3 | 2 | 8 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 3 | 2 | 7 |
| Alpha-1D adrenergic receptor | 0 | 3 | 1 | 5 |
| 5-hydroxytryptamine receptor 2C | 0 | 4 | 1 | 5 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 5 | 0 | 0 | 6 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| Reverse transcriptase/RNaseH | 0 | 0 | 1 | 2 |
| Muscarinic acetylcholine receptor | 0 | 2 | 1 | 3 |
| Leukotriene C4 synthase | 0 | 0 | 1 | 1 |
| aryl hydrocarbon receptor | 16 | 0 | 0 | 16 |
| thyroid hormone receptor beta isoform 2 | 19 | 0 | 0 | 19 |
| Bone morphogenetic protein receptor type-1B | 0 | 0 | 7 | 7 |
| Membrane-associated progesterone receptor component 1 | 0 | 0 | 6 | 6 |
| Cell division cycle 7-related protein kinase | 0 | 0 | 5 | 5 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 0 | 1 | 1 | 2 |
| Serine/threonine-protein kinase PLK4 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase 25 | 0 | 0 | 1 | 1 |
| ATP-dependent RNA helicase DDX3X | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | 0 | 0 | 1 | 1 |
| Pyridoxal kinase | 0 | 0 | 7 | 7 |
| Citron Rho-interacting kinase | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase RIO3 | 0 | 0 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 7 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase Chk1 | 0 | 0 | 7 | 7 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 1 | 1 |
| Peripheral plasma membrane protein CASK | 0 | 0 | 1 | 1 |
| Aurora kinase A | 0 | 0 | 7 | 7 |
| Cyclin-G-associated kinase | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase DCLK1 | 0 | 0 | 1 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit alpha | 0 | 0 | 1 | 1 |
| Muscle, skeletal receptor tyrosine-protein kinase | 0 | 0 | 1 | 1 |
| Ephrin type-B receptor 6 | 0 | 0 | 7 | 7 |
| Peroxisomal acyl-coenzyme A oxidase 3 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase 13 | 0 | 0 | 1 | 1 |
| 3-phosphoinositide-dependent protein kinase 1 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 13 | 0 | 0 | 1 | 1 |
| Death-associated protein kinase 3 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
| Receptor-interacting serine/threonine-protein kinase 2 | 0 | 1 | 7 | 8 |
| Mitotic checkpoint serine/threonine-protein kinase BUB1 | 0 | 0 | 7 | 7 |
| NUAK family SNF1-like kinase 1 | 0 | 0 | 1 | 1 |
| Dynamin-like 120 kDa protein, mitochondrial | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase JAK2 | 0 | 1 | 4 | 5 |
| Eukaryotic translation initiation factor 5B | 0 | 0 | 6 | 6 |
| Rho-associated protein kinase 2 | 0 | 1 | 7 | 8 |
| Serine/threonine-protein kinase ULK1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | 0 | 0 | 7 | 7 |
| Ribosomal protein S6 kinase alpha-5 | 0 | 0 | 7 | 7 |
| U5 small nuclear ribonucleoprotein 200 kDa helicase | 0 | 0 | 7 | 7 |
| Ribosomal protein S6 kinase alpha-4 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase 16 | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase PAK 3 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase-like 5 | 0 | 0 | 5 | 5 |
| Serine/threonine-protein kinase 17B | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 10 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase D3 | 0 | 1 | 7 | 8 |
| Cyclin-dependent kinase 14 | 0 | 0 | 1 | 1 |
| Structural maintenance of chromosomes protein 2 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase 6 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase OSR1 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 4 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase LATS1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase PAK 4 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase Chk2 | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 1 | 8 | 9 |
| Epidermal growth factor receptor | 0 | 3 | 7 | 10 |
| RAF proto-oncogene serine/threonine-protein kinase | 0 | 2 | 2 | 6 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 1 | 2 |
| High affinity nerve growth factor receptor | 0 | 0 | 7 | 7 |
| Cellular tumor antigen p53 | 19 | 0 | 0 | 19 |
| Guanine nucleotide-binding protein G(i) subunit alpha-2 | 0 | 0 | 6 | 6 |
| ADP/ATP translocase 2 | 0 | 0 | 7 | 7 |
| Protein kinase C beta type | 0 | 1 | 7 | 8 |
| Insulin receptor | 0 | 1 | 7 | 8 |
| Tyrosine-protein kinase Lck | 0 | 1 | 7 | 8 |
| Tyrosine-protein kinase Fyn | 0 | 2 | 7 | 9 |
| Cyclin-dependent kinase 1 | 0 | 0 | 7 | 7 |
| Glycogen phosphorylase, liver form | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase Fes/Fps | 0 | 0 | 7 | 7 |
| Macrophage colony-stimulating factor 1 receptor | 0 | 0 | 1 | 1 |
| Adenine phosphoribosyltransferase | 0 | 0 | 5 | 5 |
| Tyrosine-protein kinase Yes | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase Lyn | 0 | 0 | 7 | 7 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 1 | 7 | 8 |
| Insulin-like growth factor 1 receptor | 0 | 1 | 7 | 8 |
| Signal recognition particle receptor subunit alpha | 0 | 0 | 5 | 5 |
| Cytochrome c1, heme protein, mitochondrial | 0 | 0 | 7 | 7 |
| Hepatocyte growth factor receptor | 0 | 1 | 7 | 8 |
| Tyrosine-protein kinase HCK | 0 | 1 | 7 | 8 |
| Proto-oncogene tyrosine-protein kinase ROS | 0 | 0 | 1 | 1 |
| Platelet-derived growth factor receptor beta | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase Fgr | 0 | 0 | 5 | 5 |
| Wee1-like protein kinase 2 | 0 | 0 | 1 | 1 |
| Uncharacterized serine/threonine-protein kinase SBK3 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase A-Raf | 0 | 2 | 7 | 9 |
| Mast/stem cell growth factor receptor Kit | 0 | 1 | 1 | 2 |
| Glycogen phosphorylase, brain form | 0 | 0 | 7 | 7 |
| Breakpoint cluster region protein | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase pim-1 | 0 | 1 | 7 | 8 |
| DNA topoisomerase 2-alpha | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase 4 | 0 | 0 | 7 | 7 |
| ADP/ATP translocase 3 | 0 | 0 | 7 | 7 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 0 | 6 | 6 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 0 | 7 | 7 |
| cAMP-dependent protein kinase type II-alpha regulatory subunit | 0 | 0 | 7 | 7 |
| Insulin receptor-related protein | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase B-raf | 0 | 3 | 9 | 14 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 0 | 0 | 7 | 7 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 7 | 9 |
| Platelet-derived growth factor receptor alpha | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Fer | 0 | 0 | 7 | 7 |
| Protein kinase C alpha type | 0 | 1 | 7 | 8 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 0 | 7 | 7 |
| Vascular endothelial growth factor receptor 1 | 0 | 0 | 1 | 1 |
| General transcription and DNA repair factor IIH helicase subunit XPD | 0 | 0 | 7 | 7 |
| Interferon-induced, double-stranded RNA-activated protein kinase | 0 | 0 | 1 | 1 |
| Casein kinase II subunit alpha' | 0 | 0 | 7 | 7 |
| Ras-related protein Rab-6A | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase MAK | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 11B | 0 | 0 | 1 | 1 |
| Ephrin type-A receptor 1 | 0 | 0 | 7 | 7 |
| Receptor tyrosine-protein kinase erbB-3 | 0 | 0 | 1 | 1 |
| Multifunctional protein ADE2 | 0 | 0 | 7 | 7 |
| cAMP-dependent protein kinase catalytic subunit beta | 0 | 0 | 7 | 7 |
| Ferrochelatase, mitochondrial | 0 | 0 | 8 | 8 |
| Ribosomal protein S6 kinase beta-1 | 0 | 0 | 6 | 6 |
| Tyrosine-protein kinase JAK1 | 0 | 1 | 7 | 8 |
| Protein kinase C eta type | 0 | 1 | 1 | 2 |
| Cyclin-dependent kinase 2 | 0 | 1 | 8 | 9 |
| Beta-adrenergic receptor kinase 1 | 0 | 0 | 7 | 7 |
| Probable ATP-dependent RNA helicase DDX6 | 0 | 0 | 7 | 7 |
| Activin receptor type-2A | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 3 | 0 | 0 | 7 | 7 |
| MAP/microtubule affinity-regulating kinase 3 | 0 | 0 | 7 | 7 |
| Deoxycytidine kinase | 0 | 0 | 7 | 9 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 7 | 8 |
| Ephrin type-A receptor 2 | 0 | 0 | 7 | 7 |
| Ephrin type-A receptor 3 | 0 | 0 | 1 | 1 |
| Ephrin type-A receptor 8 | 0 | 0 | 1 | 1 |
| Ephrin type-B receptor 2 | 0 | 0 | 7 | 7 |
| Leukocyte tyrosine kinase receptor | 0 | 0 | 1 | 1 |
| Non-receptor tyrosine-protein kinase TYK2 | 0 | 0 | 7 | 7 |
| UMP-CMP kinase | 0 | 0 | 5 | 5 |
| Phosphatidylethanolamine-binding protein 1 | 0 | 0 | 6 | 6 |
| Wee1-like protein kinase | 0 | 0 | 7 | 7 |
| Heme oxygenase 2 | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase receptor UFO | 0 | 1 | 1 | 2 |
| Mitogen-activated protein kinase 4 | 0 | 0 | 1 | 1 |
| S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 7 | 7 |
| DnaJ homolog subfamily A member 1 | 0 | 0 | 7 | 7 |
| RAC-alpha serine/threonine-protein kinase | 0 | 1 | 7 | 8 |
| RAC-beta serine/threonine-protein kinase | 0 | 0 | 7 | 7 |
| G protein-coupled receptor kinase 4 | 0 | 0 | 1 | 1 |
| Dual specificity protein kinase TTK | 0 | 0 | 4 | 4 |
| DNA replication licensing factor MCM4 | 0 | 0 | 7 | 7 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 1 | 4 |
| Myosin-10 | 0 | 0 | 4 | 4 |
| Tyrosine-protein kinase receptor Tie-1 | 0 | 0 | 1 | 1 |
| Vascular endothelial growth factor receptor 3 | 0 | 1 | 1 | 2 |
| Vascular endothelial growth factor receptor 2 | 0 | 3 | 1 | 4 |
| Dual specificity mitogen-activated protein kinase kinase 2 | 0 | 5 | 7 | 12 |
| Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 7 | 8 |
| Bone morphogenetic protein receptor type-1A | 0 | 0 | 7 | 7 |
| Activin receptor type-1B | 0 | 0 | 7 | 7 |
| TGF-beta receptor type-1 | 0 | 1 | 7 | 8 |
| Serine/threonine-protein kinase receptor R3 | 0 | 0 | 4 | 4 |
| TGF-beta receptor type-2 | 0 | 0 | 7 | 7 |
| Electron transfer flavoprotein subunit beta | 0 | 0 | 6 | 6 |
| Tyrosine-protein kinase CSK | 0 | 0 | 7 | 7 |
| Glycine--tRNA ligase | 0 | 0 | 7 | 7 |
| Protein kinase C iota type | 0 | 0 | 7 | 7 |
| Exosome RNA helicase MTR4 | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 1 | 1 | 2 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0 | 1 | 1 | 2 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 1 | 2 |
| Megakaryocyte-associated tyrosine-protein kinase | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Tec | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase TXK | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase ABL2 | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase FRK | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase ZAP-70 | 0 | 1 | 1 | 2 |
| Tyrosine-protein kinase SYK | 0 | 1 | 7 | 8 |
| 26S proteasome regulatory subunit 6B | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase 8 | 0 | 1 | 7 | 8 |
| Mitogen-activated protein kinase 9 | 0 | 1 | 7 | 8 |
| Dual specificity mitogen-activated protein kinase kinase 4 | 0 | 0 | 6 | 6 |
| Dual specificity mitogen-activated protein kinase kinase 3 | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0 | 0 | 6 | 6 |
| Casein kinase I isoform alpha | 0 | 0 | 7 | 7 |
| Casein kinase I isoform delta | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 1 | 2 |
| MAP kinase-activated protein kinase 2 | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase 8 | 0 | 0 | 1 | 1 |
| Elongation factor Tu, mitochondrial | 0 | 0 | 7 | 7 |
| Choline-phosphate cytidylyltransferase A | 0 | 0 | 5 | 5 |
| Cysteine--tRNA ligase, cytoplasmic | 0 | 0 | 7 | 7 |
| Casein kinase I isoform epsilon | 0 | 0 | 7 | 7 |
| Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | 0 | 0 | 7 | 7 |
| Dual specificity protein kinase CLK1 | 0 | 0 | 7 | 7 |
| Dual specificity protein kinase CLK2 | 0 | 0 | 7 | 7 |
| Dual specificity protein kinase CLK3 | 0 | 0 | 4 | 4 |
| Glycogen synthase kinase-3 alpha | 0 | 0 | 7 | 7 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 7 | 8 |
| Cyclin-dependent kinase 7 | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase 9 | 0 | 0 | 7 | 7 |
| Ras-related protein Rab-27A | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase Blk | 0 | 0 | 1 | 1 |
| Interleukin-1 receptor-associated kinase 1 | 0 | 0 | 7 | 7 |
| Ribosomal protein S6 kinase alpha-3 | 0 | 0 | 7 | 7 |
| Cytoplasmic tyrosine-protein kinase BMX | 0 | 0 | 1 | 1 |
| cAMP-dependent protein kinase catalytic subunit PRKX | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase Nek2 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase Nek3 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase Nek4 | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase JAK3 | 0 | 1 | 1 | 2 |
| Dual specificity mitogen-activated protein kinase kinase 6 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase PLK1 | 0 | 0 | 6 | 6 |
| Death-associated protein kinase 1 | 0 | 0 | 1 | 1 |
| LIM domain kinase 1 | 0 | 0 | 7 | 7 |
| LIM domain kinase 2 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase 12 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 10 | 0 | 1 | 7 | 8 |
| Tyrosine--tRNA ligase, cytoplasmic | 0 | 0 | 7 | 7 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 7 | 7 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 1 | 1 |
| Ephrin type-B receptor 3 | 0 | 0 | 7 | 7 |
| Ephrin type-A receptor 5 | 0 | 0 | 7 | 7 |
| Ephrin type-B receptor 4 | 0 | 1 | 7 | 8 |
| Ephrin type-B receptor 1 | 0 | 0 | 1 | 1 |
| Ephrin type-A receptor 4 | 0 | 0 | 7 | 7 |
| Adenylate kinase 2, mitochondrial | 0 | 0 | 7 | 7 |
| Adenosine kinase | 0 | 0 | 6 | 6 |
| Hormonally up-regulated neu tumor-associated kinase | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase SIK1 | 0 | 0 | 1 | 1 |
| Receptor-interacting serine/threonine-protein kinase 4 | 0 | 0 | 1 | 1 |
| Ras-related protein Rab-10 | 0 | 0 | 7 | 7 |
| Cell division control protein 2 homolog | 0 | 0 | 1 | 1 |
| Actin-related protein 3 | 0 | 1 | 7 | 8 |
| Actin-related protein 2 | 0 | 0 | 6 | 6 |
| Calcium-dependent protein kinase 1 | 0 | 0 | 1 | 1 |
| GTP-binding nuclear protein Ran | 0 | 0 | 7 | 7 |
| Casein kinase II subunit alpha | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | 0 | 0 | 1 | 1 |
| SRSF protein kinase 2 | 0 | 0 | 1 | 1 |
| Casein kinase I isoform gamma-2 | 0 | 0 | 6 | 6 |
| Mitogen-activated protein kinase kinase kinase 9 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase PknB | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 3 | 0 | 0 | 6 | 6 |
| Cyclin-dependent kinase-like 1 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 6 | 0 | 0 | 7 | 7 |
| Cyclin-dependent-like kinase 5 | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase 16 | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase 17 | 0 | 0 | 7 | 7 |
| ATP-dependent 6-phosphofructokinase, platelet type | 0 | 0 | 7 | 7 |
| Protein kinase C epsilon type | 0 | 1 | 1 | 2 |
| Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 5 | 7 | 12 |
| Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 10 | 0 | 0 | 1 | 1 |
| DNA topoisomerase 2-beta | 0 | 0 | 7 | 7 |
| Protein kinase C theta type | 0 | 1 | 7 | 8 |
| Activin receptor type-1 | 0 | 0 | 7 | 7 |
| Macrophage-stimulating protein receptor | 0 | 0 | 7 | 7 |
| Focal adhesion kinase 1 | 0 | 1 | 7 | 8 |
| Protein kinase C zeta type | 0 | 1 | 3 | 4 |
| Protein kinase C delta type | 0 | 1 | 7 | 8 |
| Tyrosine-protein kinase BTK | 0 | 1 | 7 | 8 |
| Tyrosine-protein kinase receptor TYRO3 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 18 | 0 | 0 | 2 | 2 |
| Activated CDC42 kinase 1 | 0 | 0 | 7 | 7 |
| Epithelial discoidin domain-containing receptor 1 | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase ITK/TSK | 0 | 0 | 1 | 1 |
| Myotonin-protein kinase | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 2 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase 12 | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Mer | 0 | 0 | 5 | 5 |
| Serine/threonine-protein kinase 4 | 0 | 0 | 7 | 7 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase PAK 1 | 0 | 1 | 1 | 2 |
| Dual specificity mitogen-activated protein kinase kinase 5 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase 7 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase PAK 2 | 0 | 1 | 7 | 8 |
| Serine/threonine-protein kinase 3 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase 1 | 0 | 0 | 7 | 7 |
| cGMP-dependent protein kinase 2 | 0 | 0 | 1 | 1 |
| Integrin-linked protein kinase | 0 | 0 | 6 | 6 |
| Rho-associated protein kinase 1 | 0 | 1 | 7 | 8 |
| Non-receptor tyrosine-protein kinase TNK1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase PRP4 homolog | 0 | 0 | 1 | 1 |
| Receptor-interacting serine/threonine-protein kinase 1 | 0 | 1 | 1 | 2 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | 0 | 0 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma | 0 | 0 | 7 | 7 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | 0 | 0 | 7 | 7 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 7 | 7 |
| Activin receptor type-2B | 0 | 0 | 7 | 7 |
| Bone morphogenetic protein receptor type-2 | 0 | 0 | 7 | 7 |
| Protein-tyrosine kinase 6 | 0 | 0 | 7 | 7 |
| cGMP-dependent protein kinase 1 | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase 13 | 0 | 0 | 7 | 7 |
| Calcium/calmodulin-dependent protein kinase type 1 | 0 | 0 | 1 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | 0 | 0 | 7 | 7 |
| Protein-tyrosine kinase 2-beta | 0 | 0 | 7 | 7 |
| Maternal embryonic leucine zipper kinase | 0 | 0 | 7 | 7 |
| Structural maintenance of chromosomes protein 1A | 0 | 0 | 7 | 7 |
| Chromodomain-helicase-DNA-binding protein 4 | 0 | 0 | 7 | 7 |
| Peroxisomal acyl-coenzyme A oxidase 1 | 0 | 0 | 6 | 6 |
| Serine/threonine-protein kinase D1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 38 | 0 | 0 | 1 | 1 |
| Receptor tyrosine-protein kinase erbB-4 | 0 | 0 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-2 | 0 | 0 | 1 | 1 |
| Ephrin type-A receptor 7 | 0 | 0 | 6 | 6 |
| Delta(24)-sterol reductase | 0 | 0 | 7 | 7 |
| Ribosomal protein S6 kinase alpha-1 | 0 | 0 | 7 | 7 |
| Dual specificity testis-specific protein kinase 1 | 0 | 0 | 6 | 6 |
| Myosin light chain kinase, smooth muscle | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase 11 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase STK11 | 0 | 0 | 7 | 7 |
| Rhodopsin kinase GRK1 | 0 | 0 | 1 | 1 |
| NT-3 growth factor receptor | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase N1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase N2 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase 14 | 0 | 3 | 7 | 10 |
| Calcium/calmodulin-dependent protein kinase type IV | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase 11 | 0 | 0 | 7 | 7 |
| BDNF/NT-3 growth factors receptor | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 6 | 0 | 0 | 1 | 1 |
| Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 0 | 0 | 1 | 1 |
| Discoidin domain-containing receptor 2 | 0 | 0 | 7 | 7 |
| AP2-associated protein kinase 1 | 0 | 0 | 7 | 7 |
| Myosin light chain kinase 3 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase SBK1 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 19 | 0 | 0 | 1 | 1 |
| Putative heat shock protein HSP 90-beta 2 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase TNNI3K | 0 | 0 | 1 | 1 |
| Rab-like protein 3 | 0 | 0 | 7 | 7 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase MRCK alpha | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase MRCK gamma | 0 | 0 | 6 | 6 |
| Acyl-CoA dehydrogenase family member 10 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase Nek5 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase N3 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase ULK3 | 0 | 0 | 7 | 7 |
| Dual serine/threonine and tyrosine protein kinase | 0 | 1 | 1 | 2 |
| Mitogen-activated protein kinase kinase kinase 15 | 0 | 0 | 1 | 1 |
| Uncharacterized protein FLJ45252 | 0 | 0 | 7 | 7 |
| Acyl-CoA dehydrogenase family member 11 | 0 | 0 | 6 | 6 |
| Serine/threonine-protein kinase/endoribonuclease IRE2 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase MARK2 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase TAO1 | 0 | 0 | 7 | 7 |
| STE20-related kinase adapter protein alpha | 0 | 0 | 7 | 7 |
| Myosin-14 | 0 | 0 | 7 | 7 |
| AarF domain-containing protein kinase 1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase tousled-like 2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 32C | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase pim-3 | 0 | 0 | 1 | 1 |
| ATP-dependent RNA helicase DDX42 | 0 | 0 | 6 | 6 |
| Serine/threonine-protein kinase VRK2 | 0 | 0 | 1 | 1 |
| Myosin light chain kinase family member 4 | 0 | 0 | 1 | 1 |
| Homeodomain-interacting protein kinase 1 | 0 | 0 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type 1D | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 3 | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase-like 3 | 0 | 0 | 1 | 1 |
| MAP kinase-activated protein kinase 5 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase BRSK2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase NIM1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase ULK2 | 0 | 0 | 1 | 1 |
| Misshapen-like kinase 1 | 0 | 0 | 5 | 5 |
| Serine/threonine-protein kinase DCLK2 | 0 | 0 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase kinase 1 | 0 | 0 | 1 | 1 |
| Casein kinase I isoform alpha-like | 0 | 0 | 1 | 1 |
| Homeodomain-interacting protein kinase 4 | 0 | 0 | 1 | 1 |
| Myosin-IIIa | 0 | 0 | 1 | 1 |
| Ankyrin repeat and protein kinase domain-containing protein 1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase Nek11 | 0 | 0 | 1 | 1 |
| Atypical kinase COQ8A, mitochondrial | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase 15 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase Nek9 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase BRSK1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 35 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase Nek7 | 0 | 0 | 3 | 3 |
| Rhodopsin kinase GRK7 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 32A | 0 | 0 | 1 | 1 |
| Myosin-IIIb | 0 | 0 | 1 | 1 |
| ATP-dependent RNA helicase DDX1 | 0 | 0 | 7 | 7 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 2 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase-like 2 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase Sgk3 | 0 | 0 | 1 | 1 |
| Atypical kinase COQ8B, mitochondrial | 0 | 0 | 1 | 1 |
| Aurora kinase B | 0 | 0 | 7 | 7 |
| MAP/microtubule affinity-regulating kinase 4 | 0 | 0 | 7 | 7 |
| Calcium/calmodulin-dependent protein kinase type 1G | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase Nek1 | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase 15 | 0 | 0 | 1 | 1 |
| PAS domain-containing serine/threonine-protein kinase | 0 | 0 | 4 | 4 |
| Calcium/calmodulin-dependent protein kinase kinase 2 | 0 | 0 | 7 | 7 |
| EKC/KEOPS complex subunit TP53RK | 0 | 0 | 7 | 7 |
| Dual specificity testis-specific protein kinase 2 | 0 | 0 | 5 | 5 |
| SRSF protein kinase 1 | 0 | 0 | 1 | 1 |
| Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase 5 | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 3 | 0 | 0 | 7 | 7 |
| Eukaryotic translation initiation factor 2-alpha kinase 1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase RIO1 | 0 | 0 | 1 | 1 |
| MAP kinase-interacting serine/threonine-protein kinase 1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase RIO2 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 19 | 0 | 0 | 1 | 1 |
| Transient receptor potential cation channel subfamily M member 6 | 0 | 0 | 1 | 1 |
| Testis-specific serine/threonine-protein kinase 1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 33 | 0 | 0 | 1 | 1 |
| Nucleolar GTP-binding protein 1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase D2 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase DCLK3 | 0 | 0 | 1 | 1 |
| NUAK family SNF1-like kinase 2 | 0 | 0 | 6 | 6 |
| RNA cytidine acetyltransferase | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase SIK2 | 0 | 0 | 7 | 7 |
| Myosin light chain kinase 2, skeletal/cardiac muscle | 0 | 0 | 1 | 1 |
| STE20-like serine/threonine-protein kinase | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase TAO3 | 0 | 0 | 7 | 7 |
| Homeodomain-interacting protein kinase 2 | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Srms | 0 | 0 | 1 | 1 |
| Homeodomain-interacting protein kinase 3 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase PLK3 | 0 | 0 | 1 | 1 |
| dCTP pyrophosphatase 1 | 0 | 0 | 7 | 7 |
| Dual specificity protein kinase CLK4 | 0 | 0 | 7 | 7 |
| MAP kinase-interacting serine/threonine-protein kinase 2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase Nek6 | 0 | 0 | 1 | 1 |
| Casein kinase I isoform gamma-1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase PAK 6 | 0 | 0 | 5 | 5 |
| SNF-related serine/threonine-protein kinase | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase LATS2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 36 | 0 | 0 | 1 | 1 |
| Phenylalanine--tRNA ligase beta subunit | 0 | 0 | 7 | 7 |
| Isoleucine--tRNA ligase, mitochondrial | 0 | 0 | 4 | 4 |
| BMP-2-inducible protein kinase | 0 | 0 | 7 | 7 |
| Obg-like ATPase 1 | 0 | 0 | 5 | 5 |
| Midasin | 0 | 0 | 7 | 7 |
| Interleukin-1 receptor-associated kinase 4 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase 32B | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 20 | 0 | 1 | 7 | 8 |
| Cyclin-dependent kinase 12 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase PLK2 | 0 | 0 | 1 | 1 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase MARK1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase pim-2 | 0 | 0 | 6 | 6 |
| Serine/threonine-protein kinase PAK 5 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 26 | 0 | 0 | 7 | 7 |
| eIF-2-alpha kinase GCN2 | 0 | 0 | 1 | 1 |
| Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | 0 | 0 | 6 | 6 |
| Serine/threonine-protein kinase NLK | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 4-kinase beta | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 17A | 0 | 0 | 1 | 1 |
| STE20/SPS1-related proline-alanine-rich protein kinase | 0 | 0 | 1 | 1 |
| Ephrin type-A receptor 6 | 0 | 0 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase TBK1 | 0 | 0 | 7 | 7 |
| Septin-9 | 0 | 0 | 7 | 7 |
| Death-associated protein kinase 2 | 0 | 0 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-6 | 0 | 0 | 7 | 7 |
| TRAF2 and NCK-interacting protein kinase | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase tousled-like 1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase TAO2 | 0 | 0 | 7 | 7 |
| Long-chain-fatty-acid--CoA ligase 5 | 0 | 0 | 5 | 5 |
| ALK tyrosine kinase receptor | 0 | 2 | 2 | 4 |
| SRSF protein kinase 3 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase ICK | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase 11A | 0 | 0 | 1 | 1 |
| Aurora kinase C | 0 | 0 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 0 | 1 | 1 |
| RAC-gamma serine/threonine-protein kinase | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase 38-like | 0 | 0 | 5 | 5 |
| Microtubule-associated serine/threonine-protein kinase 1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase SIK3 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase 2 | 0 | 0 | 7 | 7 |
| Thyroid hormone receptor-associated protein 3 | 0 | 0 | 6 | 6 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B | 0 | 0 | 4 | 4 |
| Mitogen-activated protein kinase kinase kinase kinase 5 | 0 | 0 | 7 | 7 |
| Receptor-interacting serine/threonine-protein kinase 3 | 0 | 1 | 7 | 8 |
| Serine/threonine-protein kinase MRCK beta | 0 | 0 | 7 | 7 |
| Interleukin-1 receptor-associated kinase 3 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase 24 | 0 | 0 | 6 | 6 |
| Casein kinase I isoform gamma-3 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase 4 | 0 | 0 | 7 | 7 |
| cAMP-dependent protein kinase catalytic subunit gamma | 0 | 0 | 5 | 5 |
| Serine/threonine-protein kinase ATR | 0 | 0 | 4 | 4 |
| Cyclin-dependent kinase 10 | 0 | 0 | 5 | 5 |
| MAP kinase-activated protein kinase 3 | 0 | 0 | 4 | 4 |
| Uncharacterized aarF domain-containing protein kinase 5 | 0 | 0 | 5 | 5 |
| ATP-dependent RNA helicase DHX30 | 0 | 0 | 4 | 4 |
| Chain A, HADH2 protein | 11 | 0 | 0 | 11 |
| Chain B, HADH2 protein | 11 | 0 | 0 | 11 |
| pregnane X receptor | 7 | 0 | 0 | 7 |
| NFKB1 protein, partial | 4 | 0 | 0 | 4 |
| TDP1 protein | 25 | 0 | 0 | 25 |
| Thrombopoietin | 3 | 0 | 0 | 3 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 10 | 0 | 0 | 10 |
| progesterone receptor | 21 | 0 | 0 | 21 |
| nonstructural protein 1 | 5 | 0 | 0 | 5 |
| farnesoid X nuclear receptor | 13 | 0 | 0 | 13 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 19 | 0 | 0 | 19 |
| IDH1 | 10 | 0 | 0 | 10 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 9 | 0 | 0 | 9 |
| chromobox protein homolog 1 | 13 | 0 | 0 | 13 |
| mitogen-activated protein kinase 1 | 7 | 0 | 0 | 7 |
| serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 5 | 0 | 5 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| nuclear receptor subfamily 1, group I, member 2 | 12 | 0 | 0 | 12 |
| DNA polymerase iota isoform a (long) | 8 | 0 | 0 | 8 |
| glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
| Exportin-1 | 0 | 1 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
| NAD-dependent histone deacetylase SIR2 | 0 | 1 | 0 | 3 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
| UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A5 | 0 | 0 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 2 |
| Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 1 | 0 | 2 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
| Quinone oxidoreductase | 0 | 0 | 0 | 1 |
| Beta-secretase 1 | 0 | 1 | 0 | 1 |
| Sorbitol dehydrogenase | 0 | 1 | 0 | 1 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 2 | 0 | 2 |
| Zn finger protein | 0 | 1 | 0 | 1 |
| Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
| Fumarate hydratase | 5 | 0 | 0 | 5 |
| polyprotein | 5 | 0 | 0 | 5 |
| Pirin | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 4 | 4 |
| GTPase KRas | 0 | 2 | 0 | 2 |
| Heat shock factor protein 1 | 0 | 2 | 0 | 2 |
| Eukaryotic peptide chain release factor GTP-binding subunit ERF3B | 0 | 0 | 3 | 3 |
| apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
| 67.9K protein | 6 | 0 | 0 | 6 |
| urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
| plasminogen precursor | 3 | 0 | 0 | 3 |
| urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
| Lysine-specific demethylase 4A | 0 | 1 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha | 0 | 0 | 1 | 1 |
| Methylcytosine dioxygenase TET2 | 0 | 1 | 0 | 1 |
| Deoxyhypusine hydroxylase | 0 | 1 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 15 | 0 | 0 | 15 |
| Ataxin-2 | 18 | 0 | 0 | 18 |
| SMAD family member 2 | 11 | 0 | 0 | 11 |
| SMAD family member 3 | 11 | 0 | 0 | 11 |
| estrogen receptor 2 (ER beta) | 11 | 0 | 0 | 11 |
| peroxisome proliferator activated receptor gamma | 16 | 0 | 0 | 16 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 3 | 0 | 3 |
| Alpha-synuclein | 1 | 1 | 0 | 2 |
| TAR DNA-binding protein 43 | 5 | 0 | 0 | 5 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 3 | 3 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 2 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 6 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 6 |
| Thymidine kinase 2 | 0 | 1 | 0 | 1 |
| Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
| Cytidine deaminase | 0 | 0 | 0 | 2 |
| AAA family ATPase | 0 | 0 | 0 | 2 |
| Chain A, Sex Hormone-Binding Globulin | 0 | 0 | 1 | 1 |
| interleukin 8 | 3 | 0 | 0 | 3 |
| glp-1 receptor, partial | 8 | 0 | 0 | 8 |
| thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| Plasma kallikrein | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 1 | 21 | 7 | 37 |
| Progesterone receptor | 0 | 1 | 0 | 1 |
| Progesterone receptor | 0 | 11 | 5 | 19 |
| Glucocorticoid receptor | 0 | 4 | 2 | 7 |
| Sex hormone-binding globulin | 0 | 1 | 0 | 1 |
| Androgen receptor | 1 | 9 | 5 | 17 |
| Aromatase | 0 | 4 | 0 | 5 |
| Androgen receptor | 0 | 1 | 1 | 2 |
| Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 0 | 1 | 1 |
| Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
| Neuropeptide FF receptor 2 | 0 | 0 | 0 | 1 |
| Estrogen receptor | 1 | 8 | 3 | 12 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 1 | 7 | 3 | 11 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 10 | 0 | 0 | 10 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 4 | 0 | 0 | 4 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 4 | 0 | 0 | 4 |
| Genome polyprotein | 0 | 1 | 1 | 2 |
| Luciferase | 7 | 0 | 0 | 7 |
| acetylcholinesterase | 5 | 0 | 0 | 5 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| phosphopantetheinyl transferase | 8 | 0 | 0 | 8 |
| ATAD5 protein, partial | 9 | 0 | 0 | 9 |
| GLS protein | 5 | 0 | 0 | 5 |
| thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
| hypothetical protein, conserved | 3 | 0 | 0 | 3 |
| bromodomain adjacent to zinc finger domain 2B | 4 | 0 | 0 | 4 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 2 | 0 | 0 | 2 |
| DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
| histone acetyltransferase KAT2A isoform 1 | 8 | 0 | 0 | 8 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
| ATP-dependent phosphofructokinase | 8 | 0 | 0 | 8 |
| large T antigen | 0 | 3 | 0 | 3 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 2 |
| Pantothenate synthetase | 0 | 1 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 5 | 0 | 0 | 5 |
| nuclear receptor ROR-gamma isoform 1 | 10 | 0 | 0 | 10 |
| 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 | 0 | 1 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 2 | 0 | 2 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 2 | 0 | 2 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 2 | 0 | 2 |
| 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase | 0 | 1 | 0 | 1 |
| Sphingosine 1-phosphate receptor 1 | 0 | 0 | 1 | 1 |
| RCG53912, isoform CRA_a | 0 | 0 | 0 | 1 |
| Sphingosine kinase 1 | 0 | 0 | 0 | 1 |
| Sphingosine kinase 2 | 0 | 0 | 0 | 1 |
| Sphingosine kinase 1 | 0 | 0 | 0 | 1 |
| Smad3 | 4 | 0 | 0 | 4 |
| Glycine receptor subunit alpha-1 | 0 | 18 | 0 | 18 |
| Glycine receptor subunit beta | 0 | 18 | 0 | 18 |
| Glycine receptor subunit alpha-2 | 0 | 18 | 0 | 18 |
| Glycine receptor subunit alpha-3 | 0 | 18 | 0 | 18 |
| Spike glycoprotein | 10 | 0 | 2 | 12 |
| Ras-related C3 botulinum toxin substrate 1 | 0 | 1 | 2 | 3 |
| Chain A, DEOXYNUCLEOSIDE KINASE | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 0 | 0 | 2 | 2 |
| Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
| Transmembrane protease serine 2 | 0 | 0 | 2 | 2 |
| Procathepsin L | 0 | 0 | 2 | 2 |
| Replicase polyprotein 1a | 0 | 0 | 2 | 2 |
| Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
| Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
| Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
| Equilibrative nucleoside transporter 1 | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 2 | 2 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
| Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
| WRN | 1 | 0 | 0 | 1 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| MPI protein | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
| alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
| glucocerebrosidase | 3 | 0 | 0 | 3 |
| luciferase | 1 | 0 | 0 | 1 |
| pyruvate kinase | 2 | 0 | 0 | 2 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
| CDK5 | 0 | 0 | 0 | 1 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 0 | 1 | 1 |
| cellular tumor antigen p53 isoform a | 4 | 0 | 0 | 4 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
| intestinal alkaline phosphatase precursor | 0 | 0 | 1 | 1 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
| DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
| Vif | 0 | 1 | 0 | 1 |
| Tat | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 0 | 1 | 0 | 1 |
| alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
| endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Integrin beta-3 | 3 | 0 | 0 | 3 |
| Integrin alpha-IIb | 3 | 0 | 0 | 3 |
| Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
| Endothelin receptor type B | 2 | 0 | 0 | 2 |
| Endothelin-1 receptor | 2 | 0 | 0 | 2 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
| H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 1 |
| Chain A, Cruzipain | 4 | 0 | 0 | 4 |
| Parkin | 2 | 0 | 0 | 2 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 4 | 0 | 0 | 4 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
| caspase-3 | 1 | 0 | 0 | 1 |
| Ornithine decarboxylase | 0 | 0 | 0 | 1 |
| Adenosine receptor A3 | 0 | 3 | 1 | 4 |
| Retinoic acid receptor alpha | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 4 | 1 | 5 |
| Alpha-2B adrenergic receptor | 0 | 8 | 1 | 10 |
| Retinoic acid receptor gamma | 0 | 1 | 0 | 1 |
| Retinoic acid receptor beta | 0 | 1 | 0 | 1 |
| Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-beta | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-gamma | 0 | 1 | 0 | 1 |
| Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 1 | 5 |
| Alpha-1A adrenergic receptor | 0 | 5 | 1 | 6 |
| Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 1 | 0 | 1 |
| 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
| 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
| Cytochrome P450 26A1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 6 | 0 | 6 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Camphor 5-monooxygenase | 0 | 0 | 0 | 1 |
| Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Epoxide hydrolase 1 | 0 | 0 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
| ATP-dependent translocase ABCB1 | 0 | 7 | 1 | 10 |
| Cytochrome P450 2C11 | 0 | 2 | 0 | 2 |
| Steroid 21-hydroxylase | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 5 | 3 | 9 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
| Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A2 | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 2 | 0 | 2 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 1 | 3 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| Gonadotropin-releasing hormone receptor | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 3 | 1 | 4 |
| Cytochrome P450 4F2 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 4 | 0 | 4 |
| Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
| Lanosterol 14-alpha demethylase | 0 | 3 | 1 | 4 |
| Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
| NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 4 | 0 | 0 | 4 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 3 | 4 |
| Fatty acid-binding protein, intestinal | 0 | 1 | 1 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Caspase-1 | 0 | 2 | 0 | 2 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| Caspase-4 | 0 | 1 | 0 | 1 |
| Caspase-5 | 0 | 1 | 0 | 1 |
| Caspase-9 | 0 | 1 | 0 | 1 |
| Cell division control protein 42 homolog | 0 | 1 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| matrix metalloproteinase 1, partial | 0 | 0 | 1 | 1 |
| caspase 7, apoptosis-related cysteine protease | 2 | 0 | 0 | 2 |
| P53 | 1 | 0 | 0 | 1 |
| caspase-3 | 2 | 0 | 0 | 2 |
| cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
| cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
| neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
| Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 1 | 0 | 1 |
| Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 1 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 3 | 0 | 3 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| retinoic acid receptor alpha isoform 1 | 0 | 1 | 0 | 1 |
| retinoic acid receptor RXR-alpha isoform a | 0 | 1 | 0 | 1 |
| ClpP | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
| Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
| caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 3 |
| Tumor necrosis factor | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Platelet-activating factor receptor | 1 | 0 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| 10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
| 60 kDa chaperonin | 0 | 2 | 0 | 2 |
| 10 kDa chaperonin | 0 | 2 | 0 | 2 |
| Cystine/glutamate transporter | 0 | 1 | 0 | 1 |
| Hydroxyacid oxidase 1 | 0 | 1 | 0 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| dopamine D1 receptor | 3 | 0 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
| Toll-like receptor 4 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 2 | 4 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 0 | 1 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 3 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 2 | 4 |
| Beta-2 adrenergic receptor | 0 | 4 | 3 | 7 |
| Beta-1 adrenergic receptor | 0 | 4 | 3 | 7 |
| Beta-3 adrenergic receptor | 0 | 2 | 3 | 5 |
| Beta-1 adrenergic receptor | 0 | 4 | 2 | 7 |
| 5-hydroxytryptamine receptor 1A | 0 | 4 | 2 | 7 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 2J2 | 0 | 4 | 0 | 4 |
| Beta-2 adrenergic receptor | 0 | 1 | 2 | 4 |
| Chain A, PROGESTERONE RECEPTOR | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| Tegument protein VP16 | 0 | 0 | 1 | 1 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Coagulation factor VII | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 3 | 1 | 4 |
| Kappa-type opioid receptor | 0 | 3 | 1 | 4 |
| Progesterone receptor | 0 | 0 | 1 | 1 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 1 | 0 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-2C adrenergic receptor | 0 | 3 | 3 | 7 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-2C adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-2A adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1D adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 3 | 3 | 7 |
| Alpha-1B adrenergic receptor | 0 | 2 | 2 | 5 |
| Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
| Chain A, AKAP9-BRAF fusion protein | 0 | 1 | 0 | 1 |
| tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
| Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
| G protein-coupled receptor kinase 6 | 0 | 0 | 3 | 3 |
| Dual specificity mitogen-activated protein kinase kinase 4 | 0 | 0 | 1 | 1 |
| Aspartyl/asparaginyl beta-hydroxylase | 0 | 1 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 3 |
| D(2) dopamine receptor | 0 | 1 | 1 | 2 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 1 | 1 | 2 |
| Endothelin-1 receptor | 0 | 1 | 1 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 3 | 1 | 4 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 1 | 1 | 2 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 1 | 3 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 3 | 3 |
| Interleukin-5 | 0 | 1 | 0 | 1 |
| Interleukin-5 | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Interleukin-5 receptor subunit alpha | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
| Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
| Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 3 | 1 | 4 |
| Cyclin-A2 | 0 | 1 | 0 | 1 |
| Protein kinase C beta type | 0 | 1 | 0 | 1 |
| Cyclin-A1 | 0 | 1 | 0 | 1 |
| Peroxisome proliferator-activated receptor alpha | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | 0 | 1 | 0 | 1 |
| Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| Vpr | 1 | 0 | 0 | 1 |
| Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
| Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
| Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 1 | 2 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
| Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 2 | 0 | 2 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
| Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
| Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent taurine transporter | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Cereblon isoform 4 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| DNA-binding protein Ikaros | 0 | 0 | 0 | 1 |
| DNA damage-binding protein 1 | 0 | 1 | 1 | 2 |
| Protein cereblon | 0 | 2 | 1 | 4 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 38 | 0 | 0 | 0 | 1 |
| Chain A, Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
| Delta | 0 | 1 | 0 | 1 |
| Cycloeucalenol cycloisomerase | 0 | 1 | 0 | 1 |
| Sterol-8,7-isomerase | 0 | 1 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |